Cardiovascular Health And Risk Modification in Family Health Teams
NCT ID: NCT00787306
Last Updated: 2018-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
229 participants
INTERVENTIONAL
2008-10-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CVD Risk Reduction Trial
NCT00473785
Program for Cardiovascular Prevention and Randomized Clinical Trial
NCT01696318
Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
NCT00291824
Family Heart Health Program: Randomized, Controlled Trial
NCT00552591
Meta-Analyses of Low-risk Lifestyle Behaviours and Patient Important Outcomes
NCT03234101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multi-faceted Cardiovascular Decision Support
Risk factor active surveillance, multi-disciplinary disease management and decision aid intervention
Active risk factor surveillance
Cardiovascular risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal
Control Usual Care
Usual care in a wait-list control arm that receives the experimental intervention after 6 months.
Active risk factor surveillance
Cardiovascular risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active risk factor surveillance
Cardiovascular risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having attending a family medicine clinic for more than one year
Exclusion Criteria
* not able to read English
* requires house calls
* nursing home resident
* cognitive impairment
* current chest pain or symptoms of active coronary heart disease
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Warren McIsaac
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Warren J McIsaac, MD
Role: PRINCIPAL_INVESTIGATOR
Granovsky Gluskin Family Medicine Centre, Mount Sinai Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Granovsky Gluskin Family Medicine Cwntre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MOH-1048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.